More patients will soon be getting Zostavax to prevent shingles

More patients will soon be getting Zostavax to prevent shingles. It's for patients age 60 and over. About 50 million will be eligible.

This new vaccine reduces the risk of shingles by about 50%... and reduces postherpetic neuralgia by 67%.

And there are no significant side effects for most people.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote